Oral Rinse CpG Methylation Profiling for Early Carcinoma Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current screening techniques for oral and pharyngeal cancer lack sensitivity and are not widely used, relying on visual inspection and palpation, which are subjective and ineffective, especially for pharyngeal tumors, and there is a need for a more comprehensive and accurate diagnostic method.
Innovation Solution
A method utilizing the Infinium HumanMethylation450 BeadArray to systematically evaluate CpG island methylation in non-invasive oral rinse samples to identify a novel sentinel CpG island methylation profile for diagnosing and monitoring head and neck squamous cell carcinoma, involving steps like DNA extraction, bisulfite modification, amplification, fragmentation, hybridization with probes, and determining methylation status using labeled bases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If visual inspection and palpation are used for screening, then the method is simple and widely available, but the sensitivity and accuracy are insufficient
Solution Approach 1:
The patent replaces manual visual inspection and palpation with a molecular biology-based detection system that analyzes DNA methylation patterns in oral rinse samples. This substitution of mechanical examination with biochemical analysis dramatically improves diagnostic sensitivity while maintaining relative simplicity through standardized laboratory procedures
Solution Approach 2:
The invention shifts from examining physical characteristics (visual appearance, palpable masses) to measuring biochemical parameters (CpG island methylation status). By changing the detection parameter from macroscopic to molecular level, the system achieves superior sensitivity for detecting early-stage and pharyngeal cancers that are invisible or impalpable
2Measurement precision
If epigenome-wide strategies are used to evaluate individual loci, then comprehensive coverage is achieved, but false-discovery rate and technical noise increase
Solution Approach 1:
The patent segments the epigenome into functional units (CpG islands) and evaluates methylation at these aggregated regions rather than individual loci. This segmentation approach maintains comprehensive coverage while reducing false discoveries by averaging signals across multiple CpG sites within each island, thereby improving signal-to-noise ratio
Solution Approach 2:
The invention merges multiple individual CpG locus measurements into aggregate CpG island methylation profiles. By combining data from multiple loci within each island, the method enhances detection accuracy while mitigating technical noise and false positives that would arise from analyzing individual loci in isolation
3Measurement precision
If invasive biopsy methods are used, then diagnostic accuracy is high, but patient morbidity and discomfort increase
Solution Approach 1:
The patent uses oral rinse samples as an intermediary medium to obtain tumor DNA without direct tissue sampling. The rinse solution captures shed epithelial cells containing tumor DNA, which then serves as the analytical substrate. This intermediary approach maintains high diagnostic accuracy while completely avoiding the morbidity associated with invasive biopsies
Solution Approach 2:
The method leverages the body's natural shedding of epithelial cells into the oral cavity and allows these cells to be collected passively through rinsing. This self-service approach eliminates the need for active tissue sampling procedures, reducing patient discomfort and morbidity while preserving diagnostic capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a minimally invasive, accurate, and reliable method for early detection of oral and pharyngeal carcinoma with improved sensitivity and specificity, allowing for monitoring treatment response, using a saliva sample to diagnose cancer at an earlier stage.
Implementation Method 1
hybridization with probes, and determining methylation status using labeled bases
Data Source
AI summary
There are currently no screening tests in routine use for oral and pharyngeal cancer beyond visual inspection and palpation. Described is an improve method of detecting oral and pharyngeal cancer with a saliva sample from a subject. The method includes identifying the presence or absence of a methylation classifier in the saliva the sample. The methylation classifier is determined by the methylation status of a panel of CpG islands in the sample. In an embodiment, the methylation classifier is determined by the methylation status of between 15 and 25 CpG islands, or alternatively, 22 CpG islands. The presence of the methylation classifier indicates a diagnosis of cancer in the subject. In an embodiment, the presence of the methylation classifier is determined with a bisulfite method of determining methylation status of the CpG islands.